Evofem Biosciences has announced that two new data sets from its Phase 3 AMPOWER trial evaluating Phexxi (lactic acid, citric acid, potassium bitartrate) will be presented at the 2021 American College of Obstetricians and Gynecologists (ACOG) Annual Clinical and Scientific Meeting (ACSM). The meeting will be conducted virtually from April 30 – May 2, 2021. “These new data sets provide clinical insights into how women used Phexxi…
Rhia Ventures is on a mission is to create a vibrant U.S. market for sexual, reproductive, and maternal health that produces equitable outcomes for all. The firm makes direct investments in early- and growth-stage companies, provides technical assistance and resources to portfolio companies, and organizes corporate engagement programs to change social norms, practices, and people that influence the market. Yesterday the firm announced…
Women’s health today is under-served from innovation and clinical science standpoints with outdated practices and lack of much-needed attention from key players including investors and insurers. It is imperative to develop the eco-system, shift mindsets and embrace a holistic, women-centered approach. Today’s Fertility Innovation Summit is the second installment of Women’s Health Innovation Summit’s Women’s Health Innovation Series, which runs throughout 2021. Reproductive-health-supporting technologies and research advances…
Tulip, the world’s largest egg donor database and trusted resource for intended parents to find their ideal donor, today announced the closing of a $1.7 Million seed round. Launched in November of 2020, Tulip has quickly amassed donors from 90% of the agencies in the U.S – with nearly 20,000 egg donors within its database. The user-friendly, online search platform helps intended…
Mayne Pharma has announced that the U.S. Food and Drug Administration (FDA) has approved NEXTSTELLIS for the prevention of pregnancy. NEXTSTELLIS is the first and only contraceptive pill containing E4, a naturally occurring estrogen, now produced from a plant source, with a unique mechanism of action that offers potential advantages over other estrogens. “When speaking with patients about their contraceptive options, one…
Twentyeight Health, a digital health company offering affordable access and convenience for women’s sexual and reproductive healthcare, today announced that the company has launched in Texas. “Twentyeight Health will be expanding our Medicaid coverage of birth control to Texas residents at a time when access for women on Medicaid has been further limited,” said Amy Fan, co-founder of Twentyeight Health. “As Twentyeight…
Women First Digital (WFD), a collection of online platforms providing information and counseling services on safe abortion, contraception, and sexual and reproductive health, is launching a new WhatsApp bot extension for Ally, the world’s first ever abortion virtual assistant, in celebration of World Health Day’s 2021 theme: building a fairer, healthier world. WFD is empowering women worldwide to make informed decisions about their…
Natera, a global leader in non-invasive genetic testing and analysis of cfDNA, and Tesis Labs, a US multi-region lab services provider with labs in Colorado, Texas and Arizona, announced a strategic partnership in the field of prenatal genetic testing. The collaboration will allow Tesis to broaden its portfolio of genetic testing offerings and participate in the fast growing screening market for over 4 million pregnancies in the…
